Alivus Life Sciences Ltd.

Financial

	Alivus Life Sciences	Neuland Laboratories	IOL Chem & Pharma
Operational Metrics
API Sector
US DMF Filings	548.0 .	70.0 .	n/a
Unclassified
Number of ANDA's Filed	n/a	n/a	n/a
R&D as a % of Total Sales	3.2 %	2.79 %	0.91 %
Financials
5 yr Average ROE	37.41 %	11.99 %	9.87 %
5yr average Equity Multiplier	2.33	1.62	1.41
5yr Average Asset Turnover Ratio	0.76	0.72	1.03
5yr Avg Net Profit Margin	20.19 %	10.09 %	6.75 %
Price to Book	4.96	11.79	1.19
P/E	28.5	54.85	20.23
5yr Avg Cash Conversion Cycle	76.63 Days	45.08 Days	45.42 Days
Inventory Days	93.94 Days	89.03 Days	64.41 Days
Days Receivable	125.3 Days	86.1 Days	83.56 Days
Days Payable	114.87 Days	113.14 Days	94.27 Days
5yr Average Interest Coverage Ratio	320.13	12.92	17.62
5yr Avg ROCE	51.63 %	16.09 %	13.96 %
5yr Avg Operating Profit Margin	30.06 %	19.31 %	10.94 %
5 yr average Debt to Equity	0.0	0.21	0.03
5yr CAGR Net Profit	8.5 %	79.26 %	-4.32 %
5yr Average Return on Assets	15.32 %	7.75 %	6.97 %
Shareholdings
Promoter Holding	74.99 %	32.68 %	52.62 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-7.86 %	-3.54 %	8.93 %
Change in Mutual Fund Holding (3 Yrs)	3.09 %	6.64 %	0.0

Business

	Alivus Life Sciences	Neuland Laboratories	IOL Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Generic API 92.96 CDMO 4.67 API`s 0 Generic Drug Substances(GDS) 0 Custom Manufacturing Solutions(CMS) 0 API 0 Chemicals 0 Ethyl Acetate 0 Ibuprofen 0 Pantaprazole 0 Clopidogrel 0 Metformin 0 Others 2.37	Product Wise Break-Up Metformin 0 Clopidogrel 0 Ethyl Acetate 0 Ibuprofen 0 API 0 API`s 0 Chemicals 0 Pantaprazole 0 CDMO 0 Generic API 0 Custom Manufacturing Solutions(CMS) 39.0 Formulations 56.0 Others 5.0	Product Wise Break-Up Metformin 0 Clopidogrel 0 Ethyl Acetate 0 Ibuprofen 37.0 API 20.0 API`s 0 Chemicals 43.0 Pantaprazole 0 CDMO 0 Generic API 0 Custom Manufacturing Solutions(CMS) 0 Generic Drug Substances(GDS) 0
Location Wise Break-Up	Location Wise Break-Up India 51.09 Rest of the World 0 USA 0 Europe 0 Others 48.91	Location Wise Break-Up Rest of the World 10.44 Europe 30.51 USA 39.54 India 19.51	Location Wise Break-Up Rest of the World 26.63 Europe 0 USA 0 India 73.37
Customer Segment	Customer Segment Regulated Markets 82.0 Emerging Markets 18.0	-	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up CVS 44.0 CNS 14.0 Diabetes 5.0 Pain Management 4.0 Anticonvulsant 0 Antidepressant 0 Antibacterial 0 Others 33.0	Therapeutic Area Break-Up Anti-bacterial 19.72 CNS 0 Anticonvulsant 10.46 Pain Management 0 CVS 0 Diabetes 0 Antidepressant 11.8 Others 58.02	-
Acute vs Chronic	Acute vs Chronic Chronic 67.0 Acute 33.0	-	-
Customer Wise Break-Up	Customer Wise Break-Up External 72.4 GPL 27.6	-	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-

Alivus Life Sciences Ltd.

SIGN UP FOR FREE